Literature DB >> 8230007

Factors predicting outcome of rheumatoid arthritis: results of a followup study.

D van Zeben1, J M Hazes, A H Zwinderman, J P Vandenbroucke, F C Breedveld.   

Abstract

OBJECTIVE: To determine prognostic factors in rheumatoid arthritis (RA).
METHODS: One hundred thirty-two women with definite RA were followed yearly from an early phase of the disease (symptoms < 5 years) for a mean duration of 6 years. The prognostic value of the first available clinical and laboratory variables and assessments of functional ability was related to several outcome measures (physician's opinion of disease severity, disease activity, radiological abnormalities, functional ability and number of prescribed 2nd-line drugs) by single predictor analysis and by logistic regression.
RESULTS: The variables most predictive for one or more of the outcome measures were number of swollen joints, Ritchie score, health assessment questionnaire score, radiographical abnormalities, positive IgM rheumatoid factor (RF), positive IgG-RF, HLA-DR4, and an elevated percentage serum agalactosyl IgG. The accuracy of predicting outcome was calculated from several combinations of these variables, and varied between 70 and 80%. The accuracy based on a combination of the commonly available variables (number of swollen joints, IgM-RF and the erosion score), closely approximated the maximal accuracy that could be achieved.
CONCLUSION: The outcome of RA can be predicted by a combination of variables that are commonly available in the clinical setting.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8230007

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  42 in total

Review 1.  What will treatment of autoimmune diseases entail in 2010?

Authors:  T W Huizinga; F C Breedveld
Journal:  Springer Semin Immunopathol       Date:  2001

2.  The vitamin D receptor regulates rheumatoid arthritis synovial fibroblast invasion and morphology.

Authors:  Teresina Laragione; Anish Shah; Pércio S Gulko
Journal:  Mol Med       Date:  2012-03-27       Impact factor: 6.354

3.  Predictors of functional status in patients with early rheumatoid arthritis.

Authors:  L M Jansen; D van Schaardenburg; I E van Der Horst-Bruinsma; P D Bezemer; B A Dijkmans
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

4.  EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Authors:  B Combe; R Landewe; C Lukas; H D Bolosiu; F Breedveld; M Dougados; P Emery; G Ferraccioli; J M W Hazes; L Klareskog; K Machold; E Martin-Mola; H Nielsen; A Silman; J Smolen; H Yazici
Journal:  Ann Rheum Dis       Date:  2006-01-05       Impact factor: 19.103

Review 5.  [Early diagnosis of rheumatoid arthritis].

Authors:  M Schneider; B Ostendorf; C H Specker
Journal:  Z Rheumatol       Date:  2005-11       Impact factor: 1.372

6.  CXCL10 and its receptor CXCR3 regulate synovial fibroblast invasion in rheumatoid arthritis.

Authors:  Teresina Laragione; Max Brenner; Barbara Sherry; Pércio S Gulko
Journal:  Arthritis Rheum       Date:  2011-11

7.  Disease activity and functional changes of RA patients receiving different DMARDs in clinical practice.

Authors:  Manathip Osiri; Utis Deesomchok; Peter Tugwell
Journal:  Clin Rheumatol       Date:  2005-12-20       Impact factor: 2.980

Review 8.  Antigen-presenting cells in rheumatoid arthritis.

Authors:  R Thomas
Journal:  Springer Semin Immunopathol       Date:  1998

Review 9.  Prognostic factors of severe rheumatoid arthritis.

Authors:  R Westhovens
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

10.  T cells, fibroblast-like synoviocytes, and granzyme B+ cytotoxic cells are associated with joint damage in patients with recent onset rheumatoid arthritis.

Authors:  M C Kraan; J J Haringman; H Weedon; E C Barg; M D Smith; M J Ahern; T J M Smeets; F C Breedveld; P P Tak
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.